Latest News about Pablo Zuanic
Recent news which mentions Pablo Zuanic
With 200+ New Dispensaries And Four States Voting On Legalizing Cannabis, Could Market Expansion Squeeze Margins Further?
November 04, 2024
From Benzinga
Beyond Beer, Tilray's $1.67 Billion Market Play: Is This Cannabis Giant Still A Smart Buy?
October 29, 2024
From Benzinga
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground
October 29, 2024
From Benzinga
M&A Frenzy And Deflation Post-Election: Which Companies Are Ready To Win Big In Florida's Cannabis Market
October 26, 2024
From Benzinga
From Benzinga
EXCLUSIVE: Tilray CEO Irwin Simon On Why US Cannabis Rescheduling Won't Change A Billion-Dollar Play
October 23, 2024
From Benzinga
Village Farms Cannabis Co. Faces Nasdaq Compliance Challenge, Here's What Investors Need To Know
October 21, 2024
From Benzinga
Earnings Season Looms Large: Here's When Leading Marijuana Lender And This Cannabis Company Will Report Results
October 15, 2024
From Benzinga
Cannabis Giant Canopy Expands US Presence With Acquisition Of Top Edibles Brand: What It Means For Investors
October 09, 2024
From Benzinga
EXCLUSIVE: Cannabis Rescheduling Is Not Cure-All For Industry Problems: Experts Explain How Tax Tactics Could Hurt Marijuana Businesses In Long Run
October 08, 2024
From Benzinga
Why Canopy's 'Brand-First' Strategy Could Set It Apart From Tilray And Aurora – Here's What Investors Should Watch
October 08, 2024
From Benzinga
Experts Link Florida's Cannabis Legalization Effort To 'Monopolistic Goals,' Offer A Blueprint For Hemp Regulation
October 07, 2024
From Benzinga
From Benzinga
Billion-Dollar Cannabis Giant Tilray To Report Earnings, Here's What Investors Can Expect
October 01, 2024
From Benzinga
Hemp Under Siege: State Bans And Farm Bill To Be Discussed On Sept. 30
September 27, 2024
Tickers
NEWS
From Benzinga
LIFD's 5x Potential: Is This Psychoactive Hemp Stock The Next Big Speculative Buy?
September 25, 2024
From Benzinga
White House Highlights Marijuana Pardons Amid Skepticism Over Cannabis Rescheduling Efforts
September 24, 2024
Tickers
NEWS
From Benzinga
Hemp-Derived Products Like Delta-8 THC Are 'Here To Stay,' Says Analyst
September 20, 2024
Tickers
CCC
From Benzinga
Cannabis Investors Should Move Past 'Hopeful Phase' And Focus On Business Fundamentals, Expert Says
September 17, 2024
Tickers
CCC
From Benzinga
NASDAQ-Listed Cannabis Giant Misses Tech Rally: What Investors Need To Know About MAPS' Stock
September 17, 2024
From Benzinga
Federal Rescheduling: What It Could Mean For Cannabis Banking And Capital Markets
September 17, 2024
Tickers
CCC
From Benzinga
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
September 14, 2024
From Benzinga
Cannabis Experts Say Weed Reform Is A Race Against Time, Is The DEA Delaying Biden's Rescheduling Proposal?
September 12, 2024
From Benzinga
New Laws Could Unleash $1.7B Demand For Cannabis Loans, This Real Estate Stock Is Set To Capitalize
September 12, 2024
From Benzinga
Cannabis Giant Green Thumb Secures $150M Credit Facility, 'Strengthens Our Already Clean Balance Sheet'
September 12, 2024
From Benzinga
Will The DEA Complete Cannabis Rescheduling? Hear From Experts The Day After Harris-Trump Debate
September 10, 2024
From Benzinga
Decibel Reports 400% Dried Flower Market Growth And Expansion To UK, Australia, Israel And Germany
September 10, 2024
From Benzinga
Cannabis Flower? No, Thanks: Canadians Shift To Pre-Rolls & Vapes As Market Eyes C$5.47B
September 09, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.